Merck shares gained 3.8% in after-hours trading Tuesday following approval of its new drug for a potentially fatal lung disease.
Source link
Merck shares gained 3.8% in after-hours trading Tuesday following approval of its new drug for a potentially fatal lung disease.
Source link